We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ZyCoV-D

News List

Modi visits key vaccine facilities as COVID-19 case load surges expresspharma
November 30, 2020
The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas.
Zydus Cadila completes dosing in Phase I clinical trial of ZyCoV-D expresspharma
August 06, 2020
Zydus Cadila announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe and well-tolerated in Phase I clinical trial. The company will now commence Phase II clinical trials from August 6, 2020.
Zydus Cadila plans to complete trials of COVID-19 vaccine by March expresspharma
July 20, 2020
Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months.
Zydus starts human trials of ZyCoV-D, its COVID-19 vaccine expresspharma
July 16, 2020
The company will be enrolling over 1000 subjects across multiple clinical study sites in India for Adaptive Phase I/ II clinical trials.

Previous page 1 2 Next page